MRK - Janux Therapeutics gains amid renewed takeover speculation
2024-05-02 16:09:01 ET
More on Janux Therapeutics
- Janux Therapeutics: A Prime Target In Cancer Care's M&A Game
- Janux Therapeutics: Yes There's New Data; No It's Not A Buy Here
- Trial Data Triggers Massive Rally In Janux Therapeutics
- Janux Therapeutics jumps as much as 28% on heels of Deciphera buyout deal
- Janux a new buy at Jones on lead assets for solid tumors